Rx to Go LLC, the in-house specialty pharmacy for Florida Cancer Specialists & Research Institute LLC (FCS), announced on Tuesday that it has received re-accreditation through Accreditation Commission for Health Care (ACHC) for pharmacy services with distinction in oncology through November 2028.
In the accreditation process, healthcare organisations must demonstrate compliance with national standards. Accreditation by ACHC reflects an organisation's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care, Rx to Go said.
Rx To Go also has accreditation by URAC for Specialty Pharmacy and is dually accredited by the National Association of Boards of Pharmacy (NABP) for specialty pharmacy. FCS is also NABP accredited for digital pharmacy practice.
Rx to Go receives ACHC re-accreditation for pharmacy services
San Luis Obispo Family Dentist Publishes 'A Parent's Quick Guide to Family Dentistry'
BioDlink makes first international shipment of bevacizumab to Colombia
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Johnson & Johnson reports durable two-year remission data for TREMFYA in Crohn's disease
Jacabio reports pre-clinical data for JAB-23E73 pan-KRAS inhibitor at international conference
Orion secures exclusive commercial licence for Abzena cancer antibody
Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval
ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment
Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement
BD launches IVDR-certified self-collection solution to expand global access to HPV testing